Thyroid Cancer Treatment Choice Toolkit Available on HIPxChange
With the release of the 2015 American Thyroid Association (ATA) Management Guidelines for Adults with Differentiated Thyroid Cancer, treatment decisions for low-risk thyroid cancer became more complicated. Although the guidelines were meant to supplement shared patient-healthcare provider decision-making, the patient-provider deliberation often fails to meet the informational standards for patients and can often exclude available treatments. Low-risk thyroid cancer patients often don’t know what questions to ask, while the physicians report not knowing how to obtain patients’ preferences and include them into treatment decisions.